BRANCHBURG, NJ–( EMWNews – April 2, 2008) – Hydromer, Inc. (OTCBB: HYDI) announces that

it has entered into a two-year, self-renewing Supply and Support Agreement

with an undisclosed medical device company.

Under the terms of this non-exclusive agreement, Hydromer will supply its

proprietary and patented Hydromer® hydrophilic coatings for use on

various Pebax® plastic neurovascular and cardiovascular catheters. This

Hydromer coating system becomes slippery when made wet, improving the ease

of catheter placement and removal by the physician during complicated

procedures within the patient’s vascular system.

“In addition to a one-time upfront payment, this agreement will provide a

quarterly source of royalty revenue,” commented Martin von Dyck, Executive

Vice President of Hydromer, Inc.

For additional information, please visit the following Web site:

http://www.hydromer.com

Pebax® is a registered trademark of Arkema France Corporation.

Hydromer, Inc. is a bio-technology-based company involved in the research

and development, manufacture, contract coating and commercialization of

specialized polymer and hydrogel products for medical device, animal

health, cosmetic, personal care, and industrial uses. These technologies

range from Hydromer lubricious / anti-microbial / anti-thrombogenic /

anti-cell adhesion-proliferation / radio-opaque coatings for the medical

marketplace. Our animal health products are based around our patented

dairy cow mastitis control products sold under the T-Hexx® brand. The

Industrial coatings are primarily Anti-fog coatings for safety glasses,

aircraft windows, greenhouse panels and many other consumer applications

where strong Anti-fog properties are required. The Hydrogel products are

widely used by the cosmetics companies for use in lip-sticks, hair care,

lotions as well as by the medical industry for wound dressings, drug

delivery and implants.

For the latest information about Hydromer, Inc. and its products, please

visit our Web site at http://www.hydromer.com.